- Home
- AVTX vs PESI Comparison
AVTX vs PESI Comparison
Compare AVTX & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTX | PESI |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 243.9M |
| IPO Year | 2015 | 1992 |
Fundamental Metrics
Financial Performance| Metric | AVTX | PESI |
|---|---|---|
| Price | $14.22 | $14.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $34.50 | N/A |
| AVG Volume (30 Days) | ★ 387.9K | 148.4K |
| Earning Date | 03-19-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $192,000.00 | ★ $60,661,000.00 |
| Revenue This Year | N/A | $9.91 |
| Revenue Next Year | N/A | $62.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $6.25 |
| 52 Week High | $20.72 | $16.50 |
Technical Indicators
Market Signals| Indicator | AVTX | PESI |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 50.29 |
| Support Level | $13.50 | $14.32 |
| Resistance Level | $14.81 | $16.40 |
| Average True Range (ATR) | 1.12 | 0.89 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 32.45 | 25.00 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.